Recent

% | $
Quotes you view appear here for quick access.

Aksys Ltd. Message Board

  • xerxes2345 xerxes2345 Mar 28, 2002 6:04 PM Flag

    Daily dialysis is not so great eom

    <EOM>

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 26-Jan-01 11.63 12.63 11.63 12.44 26,600 12.44
      25-Jan-01 11.75 12.38 11.63 12.00 26,100 12.00
      24-Jan-01 11.94 12.00 11.25 11.88 108,700 11.88
      23-Jan-01 12.00 12.50 11.94 11.94 37,300 11.94
      22-Jan-01 12.88 12.94 11.50 12.25 175,400 12.25
      19-Jan-01 13.52 13.69 13.00 13.00 177,500 13.00
      18-Jan-01 14.00 14.13 13.50 13.50 22,200 13.50
      17-Jan-01 13.52 14.75 13.50 13.50 129,600 13.50
      16-Jan-01 13.52 13.75 13.38 13.75 170,700 13.75
      12-Jan-01 14.48 14.48 13.13 13.38 113,900 13.38
      11-Jan-01 13.25 14.50 13.25 14.38 101,700 14.38
      10-Jan-01 12.81 13.50 12.63 13.19 150,200 13.19
      9-Jan-01 15.06 15.06 12.88 13.63 332,600 13.63
      8-Jan-01 15.75 15.77 14.75 15.13 55,500 15.13
      5-Jan-01 16.27 16.27 15.75 16.06 302,400 16.06
      4-Jan-01 16.44 16.88 16.00 16.25 159,200 16.25
      3-Jan-01 15.50 16.50 14.63 15.88 412,300 15.88
      2-Jan-01 16.50 16.75 16.13 16.75 50,300 16.75
      29-Dec-00 16.63 16.81 15.81 16.50 185,100 16.50
      28-Dec-00 15.38 16.63 14.69 16.50 61,600 16.50
      27-Dec-00 15.48 15.50 14.69 14.69 106,300 14.69
      26-Dec-00 15.13 15.50 14.88 15.38 197,200 15.38
      22-Dec-00 14.42 15.25 14.38 15.00 26,300 15.00
      21-Dec-00 15.25 15.63 14.38 14.38

    • Where are the facts to support your opinon? AKSYS has facts that show that daily dialysis is better then thrice weekly.

    • Gee you sound like an expert! Please don't flood us with any facts or anything. If we are spending time to read posts like yours we would be too stupid to understand the facts.

    • Aksys said its "Personal Hemodialysis System" had been approved by the U.S. Food and Drug Administration without restrictions. The Lincolnshire, Ill.-based company said it plans to start shipping the product in the third quarter with the initial marketing focus on the Midwest and the Northwest.

      Shares of Aksys (AKSY: news, chart, profile) surged $4.22, or 93 percent, to $8.78.

      The company's announcement came after the close of regular trading Wednesday.

      Aksys said its system is designed to automate the dialysis process, allowing people with kidney failure to perform short daily dialysis at home. The company said studies have documented that more frequent dialysis is clinically beneficial to patients. Aksys said its system gives patients a convenient and cost-effective way to get frequent dialysis.

      "The FDA clearance is exhilarating news," Bill Dow, president and CEO, said in a statement.

      Dialysis removes waste products from the blood, a function normally handled by the kidneys. With the growing prevalence of diabetes in the United States, kidney disease -- and hence the need for dialysis -- is becoming increasingly common.

      Ted Griffith is a reporter for CBS.MarketWatch.com

    • Aksys' stock soars on FDA OK
      Firm wins clearance to sell system for home dialysis

      By Ted Griffith, CBS.MarketWatch.com
      Last Update: 4:50 PM ET March 28, 2002




      LINCOLNSHIRE, Ill. (CBS.MW) -- Aksys' stock almost doubled Thursday as investors raced to grab shares of the medical device firm after it won regulatory clearance to sell a system for home kidney dialysis.





      Free! Sign up here to receive the Real Estate Weekly e-newsletter!


      Create an alert for AKSY

      Add AKSY to my portfolio

      Discuss AKSY
      NEWS FOR AKSY
      Adelphia, QLT, Quest Software, and more
      Aksys' stock nearly doubles after FDA's OK
      Aksys' stock soars after home dialysis system OK'd
      More news for AKSY

      Quote & NewsChartsFinancialsAnalystsOptionsSEC Filings
      Quote delayed 20 minutes. Disclaimer





      Aksys said its "Personal Hemodialysis System" had been approved by the U.S. Food and Drug Administration without restrictions. The Lincolnshire, Ill.-based company said it plans to start shipping the product in the third quarter with the initial marketing focus on the Midwest and the Northwest.

      Shares of Aksys (AKSY: news, chart, profile) surged $4.22, or 93 percent, to $8.78.

      The company's announcement came after the close of regular trading Wednesday.

      Aksys said its system is designed to automate the dialysis process, allowing people with kidney failure to perform short daily dialysis at home. The company said studies have documented that more frequent dialysis is clinically beneficial to patients. Aksys said its system gives patients a convenient and cost-effective way to get frequent dialysis.

      "The FDA clearance is exhilarating news," Bill Dow, president and CEO, said in a statement.

      Dialysis removes waste products from the blood, a function normally handled by the kidneys. With the growing prevalence of diabetes in the United States, kidney disease -- and hence the need for dialysis -- is becoming increasingly common.

      Ted Griffith is a reporter for CBS.MarketWatch.com